Heidi T. May, MSPH, PhD

Original Contribution

Real-World Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors
during Percutaneous Coronary Intervention

08/01/2008

Jeffrey L. Anderson , MD;

Joseph Brent Muhlestein , MD, FAHA, FACC;

Peter J. Casterella , MD;

James R. Revenaugh , MD;

James L. Burke , MD;

Robert R. Pearson , BS;

Tami L. Bair , BS;

Heidi T. May , MSPH, PhD;

Benjamin Horne , PhD, MPH;

Percutaneous coronary intervention (PCI) is commonly employed in the management of patients with coronary artery disease (CAD), but the optimal adjunctive pharmacologic strategy for patients undergoing PCI is a frequently debated issue,...

Percutaneous coronary...

08/01/2008

Journal of Invasive Cardiology

Increased Delay from Atrial Fibrillation Diagnosis to Ablation Increases Mortality in Structural Heart Disease Patients

Purpose: Atrial Fibrillation (AF) is a common arrhythmia often comorbid with systolic or diastolic heart failure (HF). Catheter ablation is a more effective treatment for AF with concurre...

Heidi T. May , MSPH, PhD;

Andrew J. Sessions ;

Brian G. Crandall , MD;

John D. Day , MD;

Michael J. Cutler , DO, PhD;

Christopher A. Groh , MD;

Leenhapong Navaravong , MD;

Ravi Ranjan , MD, PhD;

Benjamin A. Steinberg , MD, MHS, FHRS;

T. Jared Bunch , MD;

07/19/2023